Printed From BioPortfolio.com

Global Health: In Early Results, Shorter Treatment for Tuberculosis Proves Effective

13:14 EDT 13 Oct 2017 | The New York Times News

A nine-month course of treatment seems to work as well as a longer regimen to cure drug-resistant tuberculosis, a growing threat to global health.

Original Article: Global Health: In Early Results, Shorter Treatment for Tuberculosis Proves Effective

More From BioPortfolio on "Global Health: In Early Results, Shorter Treatment for Tuberculosis Proves Effective"

Quick Links
Advanced Search | Login | Subscribe | RSS

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Tuberculosis TB
Tuberculosis (TB) is an infectious disease caused by bacteria belonging to the Mycobacterium tuberculosis complex. Over nine million new cases of TB, and nearly two million deaths from TB, are estimated to occur around the world every year, and new inf...

News Quicklinks

Search Biotech, Medical and Healthcare News

Biotech News by Article Type

Biotech News by Location

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches